A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)-Reference-Cited by-同舟云学术

A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)

Published:2017-06 Issue:6 Volume:28 Page:1333-1338
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Shamash J.,Sarker S.-J.,Huddart R.,Harland S.,Joffe J.K.,Mazhar D.,Birtle A.,White J.,Chowdhury K.,Wilson P.,Marshall M.R.,Vinnicombe S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/6/1333/17646284/mdx071.pdf

Reference16 articles.

1. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group;Toner;Lancet,2001

2. Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council

3. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial;Loehrer;J Clin Oncol,1995

4. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours;O'Sullivan;Ann Oncol,2003

5. Prospective study of the pulmonary toxicity of continuously infused bleomycin;Cooper;Cancer Treat Rep,1981

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Epithelial Ovarian Cancers;Tata Memorial Centre Textbook of Oncology;2024

2. Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis;Journal of Cancer Research and Clinical Oncology;2023-10-27

3. Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy;Frontiers in Oncology;2023-10-25

4. Management;A Guide to Management of Urological Cancers;2023

5. How can we mitigate treatment-associated morbidity in patients with germ cell tumors?;Expert Review of Anticancer Therapy;2021-06-07